Crossref

1. Novel Approaches to Immunotherapy in Triple Negative Breast Cancer

- Sanaz Tabarestani

- Mohammad Esmaeil- Akbari

- Saeed Namaki

2. Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds

- Oscar Hidalgo‐Lanussa

- Eliana Baez‐Jurado

- Valentina Echeverria

- Ghulam Md Ashraf

- Amirhossein Sahebkar

- Luis Miguel Garcia‐Segura

- Roberto C. Melcangi

- George E. Barreto

3. Long non-coding RNA GHET1 Is Possibly Involved in the Pathogenesis of a Fraction of Breast Cancers

- Shaghayegh Sarrafzadeh

- Mohammad Taheri

- Lobat Geranpayeh

- Somayyeh Ghafouri-Fard

- Soudeh Ghafouri-Fard

4. Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells

- Ling Cheng

- Ying Tang

- Xing Chen

- Lei Zhao

- Songya Liu

- Yanna Ma

- Na Wang

- Kuangguo Zhou

- Jianfeng Zhou

- Mi Zhou

5. Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis

- Omar Najim

- Konstantinos Papadimitriou

- Glenn Broeckx

- Manon Huizing

- Wiebren Tjalma

6. Association between interleukin‐1 receptor antagonist (IL‐1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web‐based analysis

- Reza Ibrahimi

- Mostafa Ibrahimi

- Behzad jamalzei

- Mohammad Esmaeil Akbari

- Mohsen Navari

- Maryam Moossavi

- Milad Khorasani

7. Importance of genetic background of oxysterol signaling in cancer

- P. Holy

- A. Kloudova

- P. Soucek

8. Genomics Role in Cancer Immunosurveillance: Impact on Immunotherapy Response

- Sanaz Tabarestani

- Mohammad Esmaeil- Akbari

- Saeed Namaki

9. Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer

- Nuri Lee

- Min-Jeong Park

- Wonkeun Song

- Kibum Jeon

- Seri Jeong

10. Omics Technologies Improving Breast Cancer Research and Diagnostics

- Arianna Orsini

- Chiara Diquigiovanni

- Elena Bonora